AKT1 and diabetes mellitus: Future research should focus on exploring genetic variability through next‐generation sequencing to identify additional variants linked to the DM–OA comorbidity, while delving deeper into the molecular mechanisms of signaling pathways like PI3K‐Akt and cAMP to uncover their roles in disease progression.